Needles, Syringes, IV Access Market Research Reports & Industry Analysis
This issue has placed a premium on the development of new products designed to prevent accidental needle sticks, which spread blood-borne pathogens.
Medical supply manufacturers around the globe are trying to develop new safety and innovative products, including sharps safety medical devices to protect health care workers. The University of Virginia’s International Healthcare Worker Safety Center lists 12 companies offering retractable needles/syringes.
The products involve a variety of technologies, for example, a safety needle device has a needle encapsulation sleeve after it has been used; the sleeve automatically resheathes the needle and locks it so that it cannot be exposed.
Blunt safety devices deploy a two-needle system, one inside the other. The inside needle is hollow and has a flat, blunt end. The outside sharp needle is used to access the vein. The inner needle moves forward and past the sharp needle to insure safety before it is removed from the patient. Such devices are known as first-generation safety products.
The retractable syringe is a unique device requiring no change in the basic procedure of delivery of the medication by health care workers. Once the injection is complete, the needle safely retracts from the patient into the syringe barrel -- thus, there is no risk of accidental needle stick injuries that can transmit HIV, hepatitis, or other infections to health care workers. Retractable syringes are considered second generation safety products.
Needles, Syringes, IV Access Industry Research & Market Reports
-
Global Intravenous (IV) Fluid Monitoring Devices Market 2025-2029
... report on the intravenous (IV) fluid monitoring devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2025
... insulin pens, syringes, pumps and injectors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to ... Read More
-
Epinephrine Autoinjectors
... CAGR of 5.5% over the analysis period 2024-2030. 0.15 gm Dosage Epinephrine Autoinjectors, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$2.7 Billion by the end ... Read More
-
Injectable Drugs Delivery
... at a CAGR of 10.1% over the analysis period 2024-2030. Devices, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$1.4 Trillion by the end of the ... Read More
-
Retractable Needle Safety Syringes
... 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Automatic, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$176.7 Million by the end ... Read More
-
Sharps Containers
... CAGR of 5.7% over the analysis period 2024-2030. Multipurpose Containers, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$352.8 Million by the end of the analysis ... Read More
-
Biopsy Needles
... CAGR of 5.7% over the analysis period 2024-2030. Vacuum-Assisted, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$971.8 Million by the end of the analysis period. ... Read More
-
Wearable Injectors
... CAGR of 9.5% over the analysis period 2024-2030. On-Body injectors, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$14.7 Billion by the end of the analysis ... Read More
-
Home Infusion Therapy
... at a CAGR of 6.7% over the analysis period 2024-2030. Infusion Pumps, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$29.4 Billion by the end of ... Read More
-
Non-PVC IV Bags
... at a CAGR of 7.7% over the analysis period 2024-2030. Single-Chamber, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.8 Billion by the end of the ... Read More
-
Syringes
... 6.8% over the analysis period 2024-2030. Prefilled Syringes, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$10.6 Billion by the end of the analysis period. Growth ... Read More
-
Intravenous (IV) Iron Drugs
... 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Ferric Carboxymaltose, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$2.3 Billion by the ... Read More
-
Needle-Free Drug Injection Systems
... 2030, growing at a CAGR of 9.5% over the analysis period 2024-2030. Jet Injectors, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$9.5 Billion by the ... Read More
-
Vaccine Delivery Devices
... at a CAGR of 4.4% over the analysis period 2024-2030. Syringes, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$5.3 Billion by the end of the ... Read More
-
Needles
... 4.9% over the analysis period 2024-2030. Conventional Needles, one of the segments analyzed in the report, is expected to record a 3.0% CAGR and reach US$6.6 Billion by the end of the analysis period. Growth ... Read More
-
Amniocentesis Needles
... CAGR of 2.1% over the analysis period 2024-2030. 150 mm & Above Needles, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$67.3 Million by the end ... Read More
-
Huber Needles
... CAGR of 4.8% over the analysis period 2024-2030. Curved Display, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$77.6 Million by the end of the analysis ... Read More
-
Dental Syringes
... CAGR of 6.2% over the analysis period 2024-2030. Non-Disposable Syringes, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$99.6 Million by the end of the analysis ... Read More
-
Pen Needles
... CAGR of 9.2% over the analysis period 2024-2030. Standard, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$2.6 Billion by the end of the analysis period. ... Read More
-
Infusion Pumps
... CAGR of 4.7% over the analysis period 2024-2030. Volumetric Infusion Pumps, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$2.2 Billion by the end of the ... Read More
-
Intravenous (IV) Solutions
... at a CAGR of 7.5% over the analysis period 2024-2030. Parenteral Nutrition, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$15.1 Billion by the end of ... Read More
-
Safety Needles
... CAGR of 6.9% over the analysis period 2024-2030. Active, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$3.2 Billion by the end of the analysis period. ... Read More
-
Aspiration & Biopsy Needles
... 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Biopsy Needles, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$1.0 Billion by the ... Read More
-
Injection Pens
... CAGR of 5.9% over the analysis period 2024-2030. Disposable Injection Pens, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$50.0 Billion by the end of the ... Read More
-
Iron Drugs
... CAGR of 7.9% over the analysis period 2024-2030. Oral Drugs, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$6.7 Billion by the end of the analysis ... Read More
Research Assistance
